Related Experiment Videos
Human monocytic ehrlichiosis in children
1Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR 72202-3591, USA.
Pediatrics
|July 1, 1997
Summary
Human monocytic ehrlichiosis (HME) in children presents with fever, rash, and severe symptoms like shock. Further research is needed to understand the long-term effects of HME in pediatric patients.
Area of Science:
- Pediatric infectious diseases
- Tick-borne illnesses
Background:
- Human monocytic ehrlichiosis (HME) is a significant concern, yet knowledge is primarily derived from adult studies.
- Limited data exists on HME's specific impact on pediatric populations.
Purpose of the Study:
- To elucidate the epidemiology of HME in children.
- To describe the clinical manifestations and outcomes of HME in pediatric patients.
- To identify risk factors and disease progression in pediatric HME cases.
Main Methods:
- Retrospective review of medical records for pediatric patients diagnosed with HME.
- Analysis of demographic, clinical, and laboratory data.
- Comparison of outcomes between patients presenting with shock and those without.
Main Results:
- Twelve pediatric HME cases were identified, with a median age of 7.4 years, predominantly from rural areas.
- Common symptoms included fever, rash, and myalgias, with frequent laboratory abnormalities like thrombocytopenia and elevated liver enzymes.
- Four patients presented in shock, requiring intensive care, longer hospitalization, and experiencing greater morbidity, including cognitive and neurologic deficits.
Conclusions:
- HME in children can lead to severe illness, including shock and potential long-term neurological complications.
- Further investigation and long-term follow-up are crucial for a comprehensive understanding of HME's spectrum in children.